Literature DB >> 16332625

Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation.

A Pfohl-Leszkowicz1, M Castegnaro.   

Abstract

Ochratoxin A (OTA) is nephrotoxic to all animal species, carcinogenic for rats and mice and probably implicated in human Balkan endemic nephropathy and the associated urothelial tract tumour. Controversial results concerning genotoxicity and biotransformation of OTA have been generated. By (32)P post-labelling technique, a dose- and time-dependent DNA adduct formation is observed in vivo and in vitro. Use of several inducers or inhibitors of biotransforming enzymes (including cytochrome P 450, cyclooxygenase, lipoxygenase, glutathione-S-transferase), demonstrated that OTA is biotransformed into genotoxic derivatives damaging for DNA. Authentic C8dG-OTA standards have been synthesized by photo-oxidation. Both of them (C-C8 & O-C8) co-migrate on TLC with two adducts formed by in vitro incubation of OTA in the presence of kidney microsomes, and in vivo in kidney of pig or rodent fed OTA as well as in kidney and bladder tumour of humans exposed to OTA. Several OTA metabolites have been isolated from tissues or cells treated by OTA. The open ring lactone (OP-OTA) and quinone OTA (OTQ) are genotoxic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16332625     DOI: 10.1080/02652030500309400

Source DB:  PubMed          Journal:  Food Addit Contam        ISSN: 0265-203X


  13 in total

1.  Mycotoxins as human carcinogens-the IARC Monographs classification.

Authors:  Vladimir Ostry; Frantisek Malir; Jakub Toman; Yann Grosse
Journal:  Mycotoxin Res       Date:  2016-11-25       Impact factor: 3.833

2.  Silibinin pretreatment protects against ochratoxin A-mediated apoptosis in primary rat hepatocytes.

Authors:  E Essid; E Petzinger
Journal:  Mycotoxin Res       Date:  2011-04-19       Impact factor: 3.833

Review 3.  Role of exposure analysis in solving the mystery of Balkan endemic nephropathy.

Authors:  David T Long; Thomas C Voice
Journal:  Croat Med J       Date:  2007-06       Impact factor: 1.351

4.  Ochratoxin A: in utero exposure in mice induces adducts in testicular DNA.

Authors:  Jamie E Jennings-Gee; Mariana Tozlovanu; Richard Manderville; Mark Steven Miller; Annie Pfohl-Leszkowicz; Gary G Schwartz
Journal:  Toxins (Basel)       Date:  2010-06       Impact factor: 4.546

5.  Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin a.

Authors:  M Marin-Kuan; V Ehrlich; T Delatour; C Cavin; B Schilter
Journal:  J Toxicol       Date:  2011-06-22

Review 6.  A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model.

Authors:  Lois A Haighton; Barry S Lynch; Bernadene A Magnuson; Earle R Nestmann
Journal:  Crit Rev Toxicol       Date:  2012-02       Impact factor: 5.635

Review 7.  Toxicity of ochratoxin a and its modulation by antioxidants: a review.

Authors:  Valeria Sorrenti; Claudia Di Giacomo; Rosaria Acquaviva; Ignazio Barbagallo; Matteo Bognanno; Fabio Galvano
Journal:  Toxins (Basel)       Date:  2013-10-11       Impact factor: 4.546

8.  In vitro glucuronidation of ochratoxin a by rat liver microsomes.

Authors:  Zheng Han; Emmanuel K Tangni; José Diana Di Mavungu; Lynn Vanhaecke; Sarah De Saeger; Aibo Wu; Alfons Callebaut
Journal:  Toxins (Basel)       Date:  2013-12-18       Impact factor: 4.546

9.  Health risk assessment of ochratoxin A for all age-sex strata in a market economy.

Authors:  T Kuiper-Goodman; C Hilts; S M Billiard; Y Kiparissis; I D K Richard; S Hayward
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2010-02

10.  Maternal-Fetal Cancer Risk Assessment of Ochratoxin A during Pregnancy.

Authors:  Chit Shing Jackson Woo; Hani El-Nezami
Journal:  Toxins (Basel)       Date:  2016-03-23       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.